Copyright
©The Author(s) 2017.
World J Clin Oncol. Jun 10, 2017; 8(3): 293-299
Published online Jun 10, 2017. doi: 10.5306/wjco.v8.i3.293
Published online Jun 10, 2017. doi: 10.5306/wjco.v8.i3.293
Figure 1 The characteristics of pancreatic neuroendocrine tumor patients at our hospital.
A total of 34 patients were diagnosed with PNETs. Among these patients, 21 had specimens that underwent Ki-67 immunostaining. There were 13 PNET G1 patients, and the observation period was more than six months long for eight PNET G1 patients. PNET: Pancreatic neuroendocrine tumor; G1: Grade 1.
- Citation: Sugimoto M, Takagi T, Suzuki R, Konno N, Asama H, Watanabe K, Nakamura J, Kikuchi H, Waragai Y, Takasumi M, Kawana S, Hashimoto Y, Hikichi T, Ohira H. Pancreatic neuroendocrine tumor Grade 1 patients followed up without surgery: Case series. World J Clin Oncol 2017; 8(3): 293-299
- URL: https://www.wjgnet.com/2218-4333/full/v8/i3/293.htm
- DOI: https://dx.doi.org/10.5306/wjco.v8.i3.293